Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Neuroimmunol ; 190(1-2): 131-8, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17825431

ABSTRACT

Leprosy is the major cause of non-traumatic neuropathy. Herein, we investigated the role of ninjurin 1, an adhesion molecule involved in nerve regeneration in leprosy. Our results demonstrated that M. leprae stimulates in vitro up-regulation of ninjurin mRNA in cultured Schwann and blood cells as well as in vivo mRNA and protein expression in leprosy nerve biopsies. A polymorphism (asp110ala) was investigated in a case-control study (1123 individuals) and no association was found with leprosy per se or with disseminated forms. Nevertheless, ala110 was associated with functional nerve impairment (OR=2.42; p=0.02 for ala/ala) and with lower mRNA levels. Our data suggests that asp110ala could be a valuable genetic marker of nerve damage in leprosy.


Subject(s)
Cell Adhesion Molecules, Neuronal/genetics , Leprosy/complications , Leprosy/genetics , Nerve Growth Factors/genetics , Peripheral Nerves/metabolism , Peripheral Nervous System Diseases/genetics , Polymorphism, Single Nucleotide/genetics , Adult , Alanine/genetics , Amino Acid Substitution/genetics , Aspartic Acid/genetics , Cell Adhesion Molecules, Neuronal/chemistry , DNA Mutational Analysis , Female , Genetic Markers/genetics , Genetic Predisposition to Disease/genetics , Genetic Testing , Genotype , Humans , Immunity, Innate/genetics , Leprosy/physiopathology , Male , Middle Aged , Nerve Growth Factors/chemistry , Peripheral Nerves/pathology , Peripheral Nerves/physiopathology , Peripheral Nervous System Diseases/diagnosis , Peripheral Nervous System Diseases/physiopathology , RNA, Messenger/metabolism , Up-Regulation/genetics
2.
São Paulo; s.n; 2007. [123] p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: lil-483821

ABSTRACT

Um dos grandes desafios terapêuticos para o câncer de bexiga é a identificação dos pacientes que inicialmente apresentam carcinoma papilífero de baixo grau, mas que irão recorrer ou progredir. Atualmente o paciente é submetido a exames regulares com cistoscopia, um método invasivo que gera grande desconforto. Sendo assim, existe a necessidade de métodos não invasivos para diagnóstico, prognóstico e monitoramento de recorrência e progressão do câncer de bexiga. Focando nossos estudos em moléculas de adesão, as quais sabidamente estão envolvidas nos processos de desenvolvimento de tumores uroteliais, procedemos com estudos de imuno-expressão, de avaliação de polimorfismos. Um total de 64 pacientes foram avaliados por imuno-histoquímica para E-caderina e beta-catenina. A imuno-expressão de E-caderina foi associada ao estadiamento clínicos dos tumores analisados (p=0,005), e há sugestão de que ela possa estar associada à sobrevida livre de progressão e a sobrevida livre de recidiva. Para beta-catenina nenhuma associação entre sua imuno-expressão e os parâmetros avaliados foi encontrada. Para o polimorfismo de ninjurina 1 foram avaliados 66 pacientes e 108 controles, sendo que um dos alelos foi associado ao grau de diferenciação tumoral...


The bladder cancer main therapeutic is the identification of patients that present at first low grade carcinoma but that will have progression. At the present time, the patient is submitted to regular cistoscopy, an invasive and painful proceeding. In this scenario new no-invasive methods are necessary to bladder cancer diagnostic, prognostic and follow-up recurrence and progression. Focusing our study in adhesion molecules, with are involved in urothelial tumor development process, we proceeded with immunohistochemistry assessing and DNA polymorphism genotyping. Sixty four patients were evaluated for immunostaining of E-cadherin and beta-catenin. E-cadherin immuno-staining were associated with clinic staging of tumors evaluated (p=0.005), and were observed a tendency to be related to free progression and free recidive survival. Neither association between beta-catenin immuno-staining and clinical parameters were observed. To ninjurin 1 polymorphism 66 patients and 108 controls were genotyped. The C allele of ninjurin 1 were associated with high grade bladder tumors...


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Cell Adhesion Molecules , Polymorphism, Genetic , Urinary Bladder Neoplasms , Immunohistochemistry , Biomarkers, Tumor
3.
Gene ; 377: 33-45, 2006 Aug 01.
Article in English | MEDLINE | ID: mdl-16644144

ABSTRACT

The parasitic helminth Schistosoma mansoni contains three HMGB proteins, HMGB1, HMGB2 and HMGB3, of primary amino acid sequences highly similar to vertebrate proteins. In this report we describe the characterization of the HMGB1 proteins and their genes from S. mansoni and Schistosoma japonicum. The deduced amino acid sequences of HMGB1 proteins from both schistosome species are identical, and comprise 176 residues. The proteins contain the two evolutionarily highly conserved HMG-box domains, A and B, exhibiting 60% similarity to mammalian HMGB1. Unlike the human HMGB1 which contains an unbroken run of 30 glutamic or aspartic residues, the SmHMGB1 or SjHMGB1 proteins possess unusually short acidic C-terminal tails (5 acidic residues interrupted by 2 serines). Southern hybridization and DNA sequencing revealed a single copy HMGB1 gene, composed of 3 exons and two introns, in S. mansoni. The exon/intron boundaries are identical to those of the human HMGB1 gene, with the exception that the second exon of the SmHMGB1 gene which is not split into two exons as in the human HMGB1 gene. RNA blot analysis revealed that the SmHMGB1 gene is constitutively expressed in similar levels both in male and female worms. The single-sized mRNA for SmHMGB1 is consistent with the size derived from the cDNA. Although DNA binding properties of SmHMGB1 (or SjHMGB1) protein seem to be similar to those previously reported with human HMGB1, i.e., preferential binding to supercoiled DNA over linear DNA, specific recognition of DNA four-way junctions, DNA-induced supercoiling in the presence of topoisomerase I, and DNA bending, we have observed two important differences relative to those observed with the human HMGB1: (i) the inability of the isolated SmHMGB1 domain A to bend DNA (as revealed by T4 ligase-mediated circularization assay), and (ii) higher DNA supercoiling and bending potential of the SmHMGB1 protein as compared to its human counterpart. The latter finding may indicate that the long acidic C-tail of human HMGB1 has much stronger repressive role on DNA bending or DNA supercoiling by topoisomerase I at physiological ionic strength than the short C-tail of the SmHMGB1 protein. Considering the important role of HMGB1 in DNA replication, transcription, recombination, and in particularly, the mediation of inflammation responses in mammalian cells, further studies on schistosome HMGB proteins may provide valuable information related to schistosomiasis, where inflammation plays a critical role in this disease.


Subject(s)
HMGB1 Protein/genetics , HMGB1 Protein/metabolism , Helminth Proteins/genetics , Helminth Proteins/metabolism , Schistosoma japonicum/genetics , Schistosoma japonicum/metabolism , Schistosoma mansoni/genetics , Schistosoma mansoni/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , DNA, Helminth/chemistry , DNA, Helminth/genetics , DNA, Helminth/metabolism , DNA, Superhelical/chemistry , DNA, Superhelical/genetics , DNA, Superhelical/metabolism , Genes, Helminth , Humans , Molecular Sequence Data , Nucleic Acid Conformation , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Schistosoma japonicum/pathogenicity , Schistosoma mansoni/pathogenicity , Sequence Homology, Amino Acid
4.
Cancer Res ; 65(5): 1693-9, 2005 Mar 01.
Article in English | MEDLINE | ID: mdl-15753364

ABSTRACT

A detailed genome mapping analysis of 213,636 expressed sequence tags (EST) derived from nontumor and tumor tissues of the oral cavity, larynx, pharynx, and thyroid was done. Transcripts matching known human genes were identified; potential new splice variants were flagged and subjected to manual curation, pointing to 788 putatively new alternative splicing isoforms, the majority (75%) being insertion events. A subset of 34 new splicing isoforms (5% of 788 events) was selected and 23 (68%) were confirmed by reverse transcription-PCR and DNA sequencing. Putative new genes were revealed, including six transcripts mapped to well-studied chromosomes such as 22, as well as transcripts that mapped to 253 intergenic regions. In addition, 2,251 noncoding intronic RNAs, eventually involved in transcriptional regulation, were found. A set of 250 candidate markers for loss of heterozygosis or gene amplification was selected by identifying transcripts that mapped to genomic regions previously known to be frequently amplified or deleted in head, neck, and thyroid tumors. Three of these markers were evaluated by quantitative reverse transcription-PCR in an independent set of individual samples. Along with detailed clinical data about tumor origin, the information reported here is now publicly available on a dedicated Web site as a resource for further biological investigation. This first in silico reconstruction of the head, neck, and thyroid transcriptomes points to a wealth of new candidate markers that can be used for future studies on the molecular basis of these tumors. Similar analysis is warranted for a number of other tumors for which large EST data sets are available.


Subject(s)
Gene Expression Profiling , Genetic Markers , Head and Neck Neoplasms/genetics , RNA, Messenger/genetics , Thyroid Neoplasms/genetics , Transcription, Genetic , Alternative Splicing , Expressed Sequence Tags , Head and Neck Neoplasms/metabolism , Humans , Larynx/metabolism , Mouth/metabolism , Pharynx/metabolism , Polymerase Chain Reaction , Protein Isoforms , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Thyroid Gland/metabolism , Thyroid Neoplasms/metabolism
5.
Arch. Clin. Psychiatry (Impr.) ; 31(1): 9-18, 2004. tab
Article in Portuguese | LILACS | ID: lil-362593

ABSTRACT

O seqüenciamento de nosso genoma representa um passo essencial no entendimento da biologia humana e no planejamento racional de pesquisas biomédicas. Contudo, é importante notar que o seqüenciamento de um dado genoma é apenas uma parte de um complexo quebra-cabeças. A informação genética deve ser usada como um mapa, a partir do qual começamos a compreender a base das doenças e a importância da variação genética através da análise da complexidade e do comportamento das regiões reguladoras, genes e proteínas, funções gênicas e sistemas celulares. Apesar dos enormes esforços para identificar genes de susceptibilidade, os resultados de estudos de genética molecular de esquizofrenia até o momento têm sido modestos. O uso apropriado da genômica poderá ajudar imensamente na elucidação das causas da esquizofrenia, permitindo avaliar o papel de novos genes, das variações genéticas, das formas de splicing alternativo, das variações de expressão gênica e de vias metabólicas de interesse. A convergência de dados bioquímicos, de imagem, de neuroanatomia, farmacológicos, clínicos e genéticos permite prever que estamos muito próximos de uma melhor compreensão das bases biológicas da esquizofrenia. A disponibilidade desses avanços terá um enorme impacto na pesquisa desta doença.


Subject(s)
Humans , Schizophrenia , Genome, Human , Polymorphism, Genetic , Forecasting
6.
Proc Natl Acad Sci U S A ; 100(23): 13418-23, 2003 Nov 11.
Article in English | MEDLINE | ID: mdl-14593198

ABSTRACT

Whereas genome sequencing defines the genetic potential of an organism, transcript sequencing defines the utilization of this potential and links the genome with most areas of biology. To exploit the information within the human genome in the fight against cancer, we have deposited some two million expressed sequence tags (ESTs) from human tumors and their corresponding normal tissues in the public databases. The data currently define approximately 23,500 genes, of which only approximately 1,250 are still represented only by ESTs. Examination of the EST coverage of known cancer-related (CR) genes reveals that <1% do not have corresponding ESTs, indicating that the representation of genes associated with commonly studied tumors is high. The careful recording of the origin of all ESTs we have produced has enabled detailed definition of where the genes they represent are expressed in the human body. More than 100,000 ESTs are available for seven tissues, indicating a surprising variability of gene usage that has led to the discovery of a significant number of genes with restricted expression, and that may thus be therapeutically useful. The ESTs also reveal novel nonsynonymous germline variants (although the one-pass nature of the data necessitates careful validation) and many alternatively spliced transcripts. Although widely exploited by the scientific community, vindicating our totally open source policy, the EST data generated still provide extensive information that remains to be systematically explored, and that may further facilitate progress toward both the understanding and treatment of human cancers.


Subject(s)
Expressed Sequence Tags , Gene Expression Regulation, Neoplastic , Neoplasms/genetics , Proteome , RNA, Messenger/metabolism , Chromosome Mapping , Databases, Genetic , Genetic Variation , Humans , Neoplasms/metabolism , Polymorphism, Single Nucleotide , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...